On Thursday, Evofem Biosciences Inc (OTCMKTS:EVFM) was in the news after it made a key new appointment and the development could bring the stock into focus today. The company announced that it had appointed a new Interim Chief Financial Officer in the form of Albert Altro.
On Thursday, EVFM stock slumped 17.45% to $0.0227 with more than 6.31 million shares, compared to volume of 2.40 million shares. The stock moved within a range of $0.0205 – 0.0270 after opening trade at $0.0255.
Evofem Biosciences Appoints Interim Chief Financial Officer
He is going to be the replacement for Jay File, who decided to quit from his position at Evofem Biosciences in order to pursue other opportunities. The appointment was a significant one and it may be a good idea for investors to consider taking a closer look at Altro’s credentials as an executive in order to make up their minds about the appointment.
Altro commands experience of more than a quarter of a century in finance and operations. His experience includes domains such as executive management, restructuring, public accounting and executive management among others. More often than not he had been executive roles while working on those domains.
Back in 2005, he had formed the company Traverse LLC but prior to that he had been employed by the consulting giant KPMG. In addition to that, he had also been in the Transaction Consulting Group at PricewaterhouseCoopers.